Dehydroepiandrosterone (DHEA) | CAS 53-43-0?
?? ?Product Overview?
Dehydroepiandrosterone (DHEA), a naturally occurring steroid hormone precursor with molecular formula ?C??H??O?? and molecular weight ?288.43 g/mol?, serves as a vital intermediate in pharmaceutical and nutraceutical industries. It is widely recognized for its role in synthesizing steroid hormones, contraceptive agents, and anti-aging supplements. Key applications include hormone therapy, metabolic regulation, and dietary supplementation.

?? ?Key Advantages?
? ?High Purity & Stability?

99% purity (USP/EP standards) with a ?2-year shelf life? under storage conditions.

?? ?Bioactive Efficacy?
Supports anti-apoptotic effects and immune modulation in preclinical studies.

??? ?Regulatory Compliance?
Meets ?ISO 9001? and ?GMP? guidelines, ensuring pharmaceutical-grade quality.

?? ?Applications?

• ?Pharmaceuticals?

  : Core intermediate for synthesizing 

  ?Abiraterone?

  , 

  ?Mifepristone?

  , and contraceptive drugs.

• ?Nutraceuticals?

  : Dietary supplements targeting age-related hormonal decline and cognitive enhancement.

• ?Research?

  : Used in studies on apoptosis, metabolic disorders, and immune response mechanisms.

?? ?Quality Certifications?

• Compliant with ?USP/EP? analytical standards.

• Batch-specific ?COA (Certificate of Analysis)? and stability testing reports available.

?? ?Market Trends?
The global steroid intermediates market is expanding rapidly, driven by rising demand for hormone therapies and anti-aging products. DHEA remains a strategic component in pharmaceutical R&D, aligning with trends toward personalized medicine and preventive healthcare.